Almujtama Alraida Medical Co.

9592.SRSAUHealthcare● Active

$24.60

+$1.10(+4.68%)

Market Cap$233700000

P/E Ratio—

52W High$33.5

52W Low$22

Avg Volume3K

Open$24.60

Beta0.15

PE Ratio Market Cap Forecast

Almujtama Alraida Medical Co. (9592.SR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

9592.sr · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Almujtama Alraida Medical Co. (9592.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9592.SR's current PE ratio of 28.15x is calculated by dividing its stock price of $24.60 by its TTM earnings per share of $0.87. −6.5% discount vs 5Y avg 30.1x

28.15x

P/E Ratio (TTM)−6.5%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E

N/A

—

EPS (TTM)

$0.87

TTM · diluted EPS

PEG Ratio

4.67

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Almujtama Alraida Medical Co. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-15

PE Ratio History

2021 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 30.1x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 5 fiscal years · Front-end computed

Average

30.1x

5-yr mean

Median

33.8x

5-yr midpoint

Minimum

15.9x

Lowest year

Maximum

38.7x

Highest year

28.1x ← Now

15.9x
MinQ1 · 25%33.8x
MedianQ3 · 75%38.7x
Max

Within Historical Range

At 28.15x, 9592.SR's current P/E is within its average historical range over the past 5 fiscal years.

40th percentileHigher than 2 of 5 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Pharmaceuticals · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Almujtama Alraida Medical Co.You 9592.SR	$234M	28.15x	+0.3%	$0.87
Arabian International Healthcare Holding Company 9530.SR	$420M	18.71x	-33.3%	$1.20
Naba Alsaha Medical Services Company 9546.SR	$480M	18.70x	-33.4%	$1.31
Al-Razi Medical Co. 9572.SR	$44M	56.50x	+101.3%	$0.54
Professional Medical Expertise Co. 9574.SR	$300M	8.14x	-71.0%	$11.92
Lana Medical Co. 9587.SR	$151M	48.80x	+73.9%	$0.05
Al-Modawat Specialized Medical Co. 9594.SR	$129M	17.52x	-37.6%	$0.27
Industry Average 6 peers with valid PE	—	28.06x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-12-31Latest FY2025	33.75x	$0.88	-9.2%
2024-12-31 FY2024	37.17x	$0.83	+48.7%
2023-12-31 FY2023	25.00x	$1.20	+57.6%
2022-12-31 FY2022	15.86x	$2.01	-59.1%
2021-12-31 FY2021	38.74x	$0.82	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $24.60 ÷ $0.87 = 28.15x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

9592.SR pe ratio · 6 questions

9592.SR's current PE ratio is 28.15x as of 2026-06-15, based on a stock price of $24.60 and TTM EPS of $0.87. Data sourced from Financial Modeling Prep via 9592.SR's SEC 10-K and 10-Q filings.

9592.SR PE ratioWhat is 9592.SR PE ratioCurrent PE ratio of 9592.SR9592.SR PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Almujtama Alraida Medical Co. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15